#5: AI diagnostics, monitoring our voice for disease, the mental health pandemic, and the future of healthcare w/ Kintsugi CEO Grace Chang

The future of the mental and cognitive health. Unpacking the groundbreaking innovation of using just our voice to identify and address cognitive issues. We cover the cost and scalability benefits of this approach, how it could identify complex conditions such as Alzheimers and Parkinsons, the role of Apple and Google, as well as the hurdles to mass adoption. Grace Chang is founder and CEO of Kintsugi. A Berkeley based technology company on a mission to scale access to mental healthcare by pioneering voice biomarker technology. With just 20 seconds of free form speech Kintsugi can pick up on depression and anxiety with over 80% clinical accuracy — and it works across multiple languages. Named by Forbes as Top 50 Ai Company, it has received almost $30M in funding from the National Science Foundation and tier 1 VCs including Insight Partners. Grace is an engineer and product developer by background, having worked as a technology leader at multiple startups that leveraged data in novel ways —including at security firm UnifyID, which would authenticate a users identity by monitoring their behavior. Sign up for new podcasts. Email me on [email protected] See omnystudio.com/listener for privacy information.